News
Zacks Small Cap Research on MSN26m
NNVC: NanoViricides Set to Initiate Phase 2 Trial in MPoxNNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback